Ginkgo Bioworks Holdings, Inc. (DNA) — SEC Filings
Ginkgo Bioworks Holdings, Inc. (DNA) — 2 SEC filings. Latest: DEFA14A (Apr 29, 2026). Includes 1 DEFA14A, 1 8-K.
View Ginkgo Bioworks Holdings, Inc. on SEC EDGAR
Overview
Ginkgo Bioworks Holdings, Inc. (DNA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Apr 29, 2026: Ginkgo Bioworks Holdings, Inc. filed a DEFA14A on April 29, 2026, which includes additional definitive proxy soliciting materials. The filing contains several graphic files related to notices, suggesting it pertains to shareholder communications or meeting preparations. The company's mailing and bus
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Ginkgo Bioworks Holdings, Inc. is neutral.
Filing Type Overview
Ginkgo Bioworks Holdings, Inc. (DNA) has filed 1 DEFA14A, 1 8-K with the SEC between Apr 2026.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 29, 2026 | DEFA14A | Ginkgo Bioworks Files Definitive Proxy Materials | low |
| Apr 7, 2026 | 8-K | 8-K Filing |
Risk Profile
Risk Assessment: Of DNA's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
proxy-filing (1) · shareholder-materials (1) · sec-filing (1)
Frequently Asked Questions
What are the latest SEC filings for Ginkgo Bioworks Holdings, Inc. (DNA)?
Ginkgo Bioworks Holdings, Inc. has 2 recent SEC filings from Apr 2026, including 1 DEFA14A, 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of DNA filings?
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.
Where can I find Ginkgo Bioworks Holdings, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ginkgo Bioworks Holdings, Inc. (DNA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ginkgo Bioworks Holdings, Inc.?
Financial highlights for Ginkgo Bioworks Holdings, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for DNA?
Investment thesis data for DNA will be available once enriched filings are processed.
Who are the key executives at Ginkgo Bioworks Holdings, Inc.?
Executive information for Ginkgo Bioworks Holdings, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Ginkgo Bioworks Holdings, Inc. stock?
Of DNA's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Ginkgo Bioworks Holdings, Inc.?
Forward guidance and predictions for Ginkgo Bioworks Holdings, Inc. are extracted from SEC filings as they are enriched.